Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > TEVA > Summary

More on TEVA

Teva Pharmaceutical Industries Limited
(TEVA)

57.10USD   Up0.18 (0.32%)   
At 2:30AM IST
 Teva Pharmaceutical Industries Limited (NasdaqNM:TEVA) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Last Trade: 57.10USD
Trade Time:2:30AM IST
Change:Up0.18 (0.32%)
Prev Close:56.92
Open:57.31
Bid:56.14 x 100
Ask:57.97 x 100
1y Target Est:65.25
Day's Range:56.72 - 57.59
52wk Range:42.00 - 59.62
Volume:4,539,807
Avg Vol (3m):4,959,040
Market Cap:50.31B
P/E (ttm):52.24
EPS (ttm):1.09
Div & Yield:0.61 (1.06%)
Add TEVA to Portfolio   Download Data

HEADLINES

 
•[video] Stock Wrap: The Real Story, February 9 - TheStreet.com  - Wed 3:22AM
•AstraZeneca Goes to the Well One Last Time - Minyanville.com  - Tue 11:20PM
•The New Danger for Foreign Investors? - Motley Fool  - Tue 9:52PM
•Five Growth Stocks With a Margin of Safety - TheStreet.com  - Tue 3:30PM
•Teva gets Nordic and Baltic rights for MS drug from Active Biotech - bizjournals.com  - Mon, Feb 8
•Teva, Active extend pact on oral MS therapy - MarketWatch  - Mon, Feb 8
•Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regions - Business Wire  - Mon, Feb 8
•Teva Settles Lawsuits for $315 Million - Fox Business  - Sat, Feb 6
•[$$] Teva Reaches Preliminary Settlement In Drug Pricing Suit - The Wall Street Journal Online  - Sat, Feb 6
•Emerging-Market ETFs Still Have Steam - TheStreet.com  - Fri, Feb 5
» More Headlines for TEVA...

ANALYST

 
EPS Est (next year) (Dec-09) :3.37
EPS Est (in 2 years) (Dec-10) :4.52
Avg Rec (current)*:1.6
PEG Ratio:1.15
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
Teva Pharmaceutical Industries Limited engages in the development, production, and sale of a range of generic and branded pharmaceuticals, biogenerics, and active pharmaceutical ingredients (APIs) worldwide.

» Full Company Profile